The Neuro-Oncology Program at Harvard Cancer Consortium (HCC), the Department of Neurobiology at Harvard Medical School, and the Department of Neurology at Brigham and Women’s Hospital are seeking post-doctoral trainee applications for a T32 Training Grant in Cancer Neuroscience. This T32 program includes 30 faculty engaged in a wide scope of cancer neuroscience research across all DF/HCC institutions. Broad areas of expertise include cancer therapeutics, imaging/molecular pathology, axon biology, neuroimmunology, and neuronal microenvironment. The training program includes supervised laboratory research, coursework, regular seminars, sponsored attendance at national meetings, and presentations at an annual retreat. We are seeking applications internal to HCC as well as external applicants. The training program is open to PhD, MD, and MD/PhD candidates. At the time of award the trainee must be a citizen of the United States, or a non-citizen national, or permanent resident (foreign nationals with student visas are not eligible).
The application deadline for a 2026 training start date is now closed. Our T32 Trainee Oversight Committee will select post-doctoral trainees for a typical training program of 2 years.
When the 2027 application period opens, applications will consist of the following components, to be submitted as single PDF document:
- Statement of research interest (1 page maximum)
- Statement of affirmation to participate in all program activities (1 paragraph maximum)
- Curriculum vitae (HMS format for all internal applicants)
- 3 letters of recommendation (at least one internal/mentor letter for internal applicants)
Applications should be submitted to Olga Katsovskiy (okatsovskiy@bwh.harvard.edu).
Program Directors
This program is supported by the National Cancer Institute of the National Institutes of Health under Award Number T32CA272386.
